Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil for dementia with Lewy bodies (DLB)
jRCT2080221356Phase 3
- Sponsor
- Eisai Co., Ltd.
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in dementia with Lewy bodies (DLB) comparing Donepezil with Placebo (2 arms).
02
Drugs
donepezil
03
Conditions
dementia with Lewy bodies (DLB)
Beyond the preview
Go deeper on jRCT2080221356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221356.